Semaglutide is a glucagon-like peptide 1 (GLP-1) receptor agonist
Wu L, Xia M, Duan Y, Zhang L, Jiang H, Hu X, Yan H, Zhang Y, Gu Y, Shi H, Li J, Gao X, Li J
Since some studies show that GLP-1 drugs may have an impact on addictive behaviors, this makes scientists wonder what other neurological impacts the drug can have
It presents the dual mechanism as potentially amplifying effects while stressing that individual response still varies
High purity batches with third-party COAs Quality-controlled manufacturing standards Professional research-grade sourcing Important Note This content is provided for informational and research-education purposes only and is not medical advice, diagnosis, or treatment guidance